ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
Onestream Inc
20.95
-0.3150
-1.48%
成交量:
11.48萬
成交額:
241.41萬
市值:
36.87億
市盈率:
-16.79
高:
21.33
開:
21.31
低:
20.78
收:
21.26
資料載入中...
總覽
公司
新聞
公告
Onestream, Inc.盤中異動 股價大跌5.04%報28.84美元
市场透视
·
01-28
多發性骨髓瘤治療藥物新適應症獲批 耐藥性推動腫瘤藥研發新需求
第一财经
·
01-25
Onestream, Inc.盤中異動 股價大漲5.01%報29.33美元
市场透视
·
01-16
Onestream, Inc.盤中異動 下午盤大幅上漲5.04%報27.42美元
市场透视
·
01-16
Onestream, Inc.盤中異動 大幅上漲5.12%
市场透视
·
01-11
本田CES發佈面向未來0系列,首款“美國造”電動車明年面世,自動駕駛軟件AI加持
华尔街见闻
·
01-08
恆瑞正式遞表港交所,開啓國際化的第二步
华尔街见闻
·
01-07
中國國家藥品監督管理局批准威絡益(佐妥昔單抗)一線治療晚期胃或胃食管交界處腺癌
美通社
·
01-06
利普卓®在華獲批用於gBRCA突變HER2陰性早期高風險乳腺癌的輔助治療
美通社
·
01-03
泰瑞沙®在中國獲批治療EGFR突變Ⅲ期不可切除非小細胞肺癌
美通社
·
01-02
科倫博泰生物塔戈利單抗獲批上市
财中社
·
2024-12-31
腫瘤藥競賽,上了新高度
蓝鲸财经
·
2024-12-22
Onestream, Inc.盤中異動 股價大跌5.04%
市场透视
·
2024-12-14
Onestream, Inc.盤中異動 大幅下挫5.20%報29.10美元
市场透视
·
2024-12-09
Onestream, Inc.盤中異動 股價大漲5.01%報31.85美元
市场透视
·
2024-12-04
無AI,不手機?
蓝洞商业
·
2024-12-03
Onestream, Inc.盤中異動 股價大跌5.02%報30.39美元
市场透视
·
2024-11-28
吉利德近期宣佈多個裁員計劃:腫瘤業務遇阻,一年兩針的艾滋病“神藥”能否撐起未來?
每日经济新闻
·
2024-11-23
吉利德腫瘤藥賣不動了?新藥失利、裁員調整
医药经济报
·
2024-11-20
Onestream, Inc.2024財年第三財季實現淨利潤-1.72億美元,同比減少2644.38%
市场透视
·
2024-11-17
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/OS/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OS\",,,,,undefined,":{"symbol":"OS","market":"US","secType":"STK","nameCN":"Onestream Inc","latestPrice":20.945,"timestamp":1746025146349,"preClose":21.26,"halted":0,"volume":114798,"delay":0,"floatShares":70199725,"shares":176023203,"eps":-1.247698,"marketStatus":"交易中","change":-0.315,"latestTime":"04-30 10:59:13 EDT","open":21.31,"high":21.33,"low":20.775,"amount":2414051.2102260003,"amplitude":0.026105,"askPrice":20.99,"askSize":10,"bidPrice":20.91,"bidSize":211,"shortable":3,"etf":0,"ttmEps":-1.247698,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1746043200000},"marketStatusCode":2,"adr":0,"listingDate":1721793600000,"exchange":"NASDAQ","adjPreClose":21.26,"preHourTrading":{"tag":"盘前","latestPrice":21.25,"preClose":21.26,"latestTime":"09:29 EDT","volume":215,"amount":4575.579905,"timestamp":1746019799999},"postHourTrading":{"tag":"盘后","latestPrice":21.16,"preClose":21.26,"latestTime":"16:07 EDT","volume":7055,"amount":149947.28,"timestamp":1745957229565},"volumeRatio":0.683844,"impliedVol":0.7549,"impliedVolPercentile":0.8783},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OS\",,,,,undefined,":{"symbol":"OS","floatShares":70199725,"roa":"-33.71%","roe":"-102.65%","lyrEps":-1.232998,"volumeRatio":0.683844,"shares":176023203,"dividePrice":0,"high":21.33,"amplitude":0.026105,"preClose":21.26,"low":20.775,"week52Low":16.6942,"pbRate":"9.55","psRate":"7.53","week52High":35.39,"institutionHeld":0,"latestPrice":20.945,"committee":0.909502,"eps":-1.247698,"divideRate":0,"volume":114798,"delay":0,"ttmEps":-1.247698,"open":21.31,"prevYearClose":28.52,"prevWeekClose":21.29,"prevMonthClose":21.34,"prevQuarterClose":21.34,"fiveDayClose":20.21,"twentyDayClose":22.68,"sixtyDayClose":28.585,"earningDate":1746633600000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OS\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2506593589","title":"Onestream, Inc.盤中異動 股價大跌5.04%報28.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506593589","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506593589?lang=zh_tw&edition=fundamental","pubTime":"2025-01-28 03:06","pubTimestamp":1738004799,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日03时06分,Onestream, Inc.股票出现波动,股价急速下挫5.04%。截至发稿,该股报28.84美元/股,成交量51.045万股,换手率0.22%,振幅5.67%。Onestream, Inc.股票所在的软件服务行业中,整体跌幅为1.67%。其相关个股中,极光、Orangekloud Technology Inc.、Microalgo, Inc.涨幅较大,Microalgo, Inc.、极光、Orangekloud Technology Inc.较为活跃,换手率分别为674.23%、559.59%、159.74%,振幅较大的相关个股有极光、Orangekloud Technology Inc.、Nvni Group Limited,振幅分别为154.85%、111.59%、82.95%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280306409874d820&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280306409874d820&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OS","BK4097"],"gpt_icon":0},{"id":"2506617873","title":"多發性骨髓瘤治療藥物新適應症獲批 耐藥性推動腫瘤藥研發新需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2506617873","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506617873?lang=zh_tw&edition=fundamental","pubTime":"2025-01-25 20:18","pubTimestamp":1737807495,"startTime":"0","endTime":"0","summary":"1月24日,赛诺菲抗CD38单抗艾沙妥昔单抗注射液(商品名:赛可益)的一项新适应症获得国家药品监督管理局(NMPA)批准,这也是该药物本月获批的第二项适应症,用于与硼替佐米、来那度胺和地塞米松(VRd)联合,治疗不适合自体干细胞移植(ASCT)的新诊断的多发性骨髓瘤(NDMM)成人患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202501253308273566.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202501253308273566.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["OS","BK4097","BK4017","CDE"],"gpt_icon":0},{"id":"2503913994","title":"Onestream, Inc.盤中異動 股價大漲5.01%報29.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503913994","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503913994?lang=zh_tw&edition=fundamental","pubTime":"2025-01-16 22:39","pubTimestamp":1737038383,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日22时39分,Onestream, Inc.股票出现异动,股价急速拉升5.01%。截至发稿,该股报29.33美元/股,成交量14.5526万股,换手率0.06%,振幅2.90%。Onestream, Inc.股票所在的软件服务行业中,整体涨幅为0.36%。Onestream, Inc.公司简介:OneStream Inc 是一个支持人工智能的可扩展软件平台,将核心财务功能和更广泛的运营数据和流程统一到一个平台上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116223943a224617b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116223943a224617b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4097","OS"],"gpt_icon":0},{"id":"2503673701","title":"Onestream, Inc.盤中異動 下午盤大幅上漲5.04%報27.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503673701","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503673701?lang=zh_tw&edition=fundamental","pubTime":"2025-01-16 02:24","pubTimestamp":1736965478,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日02时24分,Onestream, Inc.股票出现异动,股价急速上涨5.04%。截至发稿,该股报27.42美元/股,成交量35.4235万股,换手率0.15%,振幅4.14%。Onestream, Inc.股票所在的软件服务行业中,整体涨幅为2.19%。Onestream, Inc.公司简介:OneStream Inc 是一个支持人工智能的可扩展软件平台,将核心财务功能和更广泛的运营数据和流程统一到一个平台上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501160224389604e762&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501160224389604e762&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4097","OS"],"gpt_icon":0},{"id":"2502949648","title":"Onestream, Inc.盤中異動 大幅上漲5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502949648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502949648?lang=zh_tw&edition=fundamental","pubTime":"2025-01-11 00:38","pubTimestamp":1736527137,"startTime":"0","endTime":"0","summary":"北京时间2025年01月11日00时38分,Onestream, Inc.股票出现异动,股价快速上涨5.12%。Onestream, Inc.股票所在的软件服务行业中,整体跌幅为1.89%。其相关个股中,Datchat, Inc.、Datchat Inc C/Wts 17/08/2026 、Nvni Group Ltd C/Wts 01/11/2028涨幅较大,Datchat, Inc.、Firefly Neuroscience, Inc.、Intrusion Inc.较为活跃,换手率分别为2669.19%、60.28%、50.83%,振幅较大的相关个股有Datchat, Inc.、Helport Ai Ltd C/Wts Exp 31/03/2029、Nvni Group Ltd C/Wts 01/11/2028,振幅分别为99.69%、83.29%、67.98%。Onestream, Inc.公司简介:OneStream Inc 是一个支持人工智能的可扩展软件平台,将核心财务功能和更广泛的运营数据和流程统一到一个平台上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111003857aba61fd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111003857aba61fd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OS","BK4097"],"gpt_icon":0},{"id":"2501737834","title":"本田CES發佈面向未來0系列,首款“美國造”電動車明年面世,自動駕駛軟件AI加持","url":"https://stock-news.laohu8.com/highlight/detail?id=2501737834","media":"华尔街见闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501737834?lang=zh_tw&edition=fundamental","pubTime":"2025-01-08 04:41","pubTimestamp":1736282504,"startTime":"0","endTime":"0","summary":"本田在CES展示两款0系列原型车——轿车和SUV,均将在美国的工厂制造,其中SUV的量产车2026年上半年首先在北美上市,轿车同年底开始生产。0系列车都将搭载名为ASIMO OS的操作系统,以及本田与无监督学习初创公司 Helm.AI 共同开发的自动驾驶软件。本田将与瑞萨电子共同为0系列车开发高性能系统级芯片(SoC)。","market":"us","thumbnail":"https://wpimg-wscn.awtmt.com/3992b2a4-8e4a-4cce-85d4-1f9a85cbab71.jpeg","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/3992b2a4-8e4a-4cce-85d4-1f9a85cbab71.jpeg"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3738599","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3738599","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"本田CES发布面向未来0系列,首款“美国造”电动车明年面世,自动驾驶软件AI加持","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["BK4097","OS"],"gpt_icon":0},{"id":"2501721910","title":"恆瑞正式遞表港交所,開啓國際化的第二步","url":"https://stock-news.laohu8.com/highlight/detail?id=2501721910","media":"华尔街见闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501721910?lang=zh_tw&edition=fundamental","pubTime":"2025-01-07 09:53","pubTimestamp":1736214790,"startTime":"0","endTime":"0","summary":"通过登陆港股,恒瑞将进一步巩固海外市场的业务基础,强化其产品出海后的国际影响力。","market":"us","thumbnail":"https://wpimg-wscn.awtmt.com/f3b15131-9c3b-4c18-a3da-edc7385f766c.jpeg","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/f3b15131-9c3b-4c18-a3da-edc7385f766c.jpeg"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3738517","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3738517","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["BK4097","BK4195","BK1161","06978","OS","BK4211","PFS","AGT","BK1574"],"gpt_icon":0},{"id":"2501532952","title":"中國國家藥品監督管理局批准威絡益(佐妥昔單抗)一線治療晚期胃或胃食管交界處腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2501532952","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501532952?lang=zh_tw&edition=fundamental","pubTime":"2025-01-06 20:25","pubTimestamp":1736166300,"startTime":"0","endTime":"0","summary":"胃癌是中国与癌症相关死亡的第三大因素,2022年导致超过26万例死亡。近日国家药品监督管理局批准了佐妥昔单抗在中国上市,我们非常激动,它将为我国晚期胃癌患者增添一项宝贵且有效的一线治疗选择。SPOTLIGHT研究探索了佐妥昔单抗联合化疗方案在CLDN18.2阳性、HER2阴性晚期胃和胃食管交界处癌患者一线治疗中的疗效与安全性,在PFS与OS等关键指标上,呈现出统计学上的显著差异。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4589327_ZH89327_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4527","LU0942090050.USD","LU2506951958.HKD","CDC","IE00B42XCP33.USD","LU1059921491.USD","SG9999001424.SGD","BK4515","IE00BSNM7G36.USD","BK4533","BK4097","SG9999015952.SGD","LU2237443978.SGD","SG9999002232.USD","LU2286300806.USD","SG9999015986.USD","LU0823417653.USD","LU2237443895.HKD","LU0234570918.USD","LU1880398554.USD","LU2237443465.HKD","OS","LU1880398471.USD","IE00BVYPNW00.USD","BK4211","LU1235294995.USD","LU1244550221.USD","LU1066051811.HKD","LU0950375773.USD","BK4534","LU0234572021.USD","LU1066051225.USD","PFS","LU1066053197.SGD","LU1823568750.SGD","BK4007","IE00BVYPNV92.GBP","ALPMY","IE00BFXG1179.USD","BK4525","BK4588","LU1571399168.USD","LU1894683348.USD","IE00BGHQF631.EUR","CSCO","SG9999015978.USD","SG9999015945.SGD","LU2506952170.USD","SG9999001440.SGD","LU2506952097.USD"],"gpt_icon":0},{"id":"2500962361","title":"利普卓®在華獲批用於gBRCA突變HER2陰性早期高風險乳腺癌的輔助治療","url":"https://stock-news.laohu8.com/highlight/detail?id=2500962361","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500962361?lang=zh_tw&edition=fundamental","pubTime":"2025-01-03 12:07","pubTimestamp":1735877220,"startTime":"0","endTime":"0","summary":"奥拉帕利是中国首个获批用于早期乳腺癌针对gBRCA突变的靶向治疗药物,此次获批有望改变乳腺癌高危患者的治疗格局。此次奥拉帕利的获批为我国gBRCA突变的早期乳腺癌患者带来了新的辅助治疗选择,有望改变早期乳腺癌的治疗格局,使更多癌症患者获益于该创新疗法。基于OlympiA III期临床试验结果,目前奥拉帕利已在美国、欧盟、日本及许多其他国家和地区获批用于治疗gBRCAm、HER2阴性早期高风险乳腺癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4587308_ZH87308_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU0109394709.USD","LU2236285917.USD","BK4588","BK4585","LU0320765992.SGD","LU2417539215.USD","BK4097","OS","LU2456880835.USD","LU2462157665.USD","LU1829250122.USD","LU0889565916.HKD","BK4568","BK4007","AZN"],"gpt_icon":0},{"id":"2500337929","title":"泰瑞沙®在中國獲批治療EGFR突變Ⅲ期不可切除非小細胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2500337929","media":"美通社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500337929?lang=zh_tw&edition=fundamental","pubTime":"2025-01-02 20:18","pubTimestamp":1735820280,"startTime":"0","endTime":"0","summary":"中国患者的临床获益和全球患者一致:接受奥希替尼治疗组12个月和24个月的PFS率分别为80%、71%,而安慰剂组仅为17%和8%[4]。Ⅲ期肺癌分为可切除、潜在切除和不可切除三大类,其中不可切除的Ⅲ期非小细胞肺癌患者占大多数[6],病程进展最为严峻。非常高兴看到奥希替尼治疗EGFR突变Ⅲ期不可切除肺癌的适应症在中国获批,填补了几十年来的临床空白,这对不可切除的EGFR突变Ⅲ期肺癌患者来说是一个重大突破,为他们带来长生存的希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4587876_ZH87876_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU1829250122.USD","CRT","BK4135","BK4213","CNS","LU2236285917.USD","AZN","BK4097","LU2462157665.USD","CDE","LU0320765992.SGD","BK4568","OS","BK4211","LU0109394709.USD","PFS","BK4007","LU2417539215.USD","BK4017","BK4588","LU0889565916.HKD","BK4195","BK4585","LU2456880835.USD"],"gpt_icon":0},{"id":"2495989316","title":"科倫博泰生物塔戈利單抗獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2495989316","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495989316?lang=zh_tw&edition=fundamental","pubTime":"2024-12-31 18:28","pubTimestamp":1735640915,"startTime":"0","endTime":"0","summary":"财中社12月31日电科伦博泰生物-B(06990)发布公告,宣布其用于治疗既往接受过2线及以上化疗失败的复发或转移性鼻咽癌患者的靶向单抗塔戈利单抗(前称KL-A167,科泰莱?)已获得中国国家药品监督管理局批准上市。此次获批主要基于一项在132例患者中进行的II期临床研究,评估塔戈利单抗的有效性和安全性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412313284181760.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","LU0196878994.USD","BK4097","06990","OS"],"gpt_icon":0},{"id":"2493260769","title":"腫瘤藥競賽,上了新高度","url":"https://stock-news.laohu8.com/highlight/detail?id=2493260769","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493260769?lang=zh_tw&edition=fundamental","pubTime":"2024-12-22 08:43","pubTimestamp":1734828238,"startTime":"0","endTime":"0","summary":"过去几年,强生在骨髓瘤领域,给市场上了一课。目前,强生富有层次感的交接棒正在形成,相关产品2023年收入也已突破百亿美元大关。这或许也预示了,肿瘤药的竞赛,在不知不觉中已经上了新高度。在这一逻辑下,肿瘤药物的竞争高度不断上行。这也是头部肿瘤药企进行广泛而精准布局的核心。一方面,泽布替尼表现强势,是全球获批适应症最广泛且在CLL新患市场取得领导地位的新一代BTK抑制剂,支","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/247504","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4505","BK4585","BGNE","LU1969619763.USD","BK1588","BK4211","BK4548","BK1161","BK4588","LU0588546209.SGD","LU2328871848.SGD","BK4097","BK4535","BK1583","BK4504","BK1500","LU0307460666.USD","OS","PFS","06160","BK4526","BK4139","BK4195"],"gpt_icon":0},{"id":"2491303719","title":"Onestream, Inc.盤中異動 股價大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491303719","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491303719?lang=zh_tw&edition=fundamental","pubTime":"2024-12-14 01:09","pubTimestamp":1734109750,"startTime":"0","endTime":"0","summary":"北京时间2024年12月14日01时09分,Onestream, Inc.股票出现波动,股价急速下挫5.04%。Onestream, Inc.股票所在的软件服务行业中,整体跌幅为0.74%。Onestream, Inc.公司简介:OneStream Inc 是一个支持人工智能的可扩展软件平台,将核心财务功能和更广泛的运营数据和流程统一到一个平台上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214010910ab75d240&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214010910ab75d240&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4097","OS"],"gpt_icon":0},{"id":"2490748427","title":"Onestream, Inc.盤中異動 大幅下挫5.20%報29.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490748427","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490748427?lang=zh_tw&edition=fundamental","pubTime":"2024-12-09 23:43","pubTimestamp":1733758993,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日23时43分,Onestream, Inc.股票出现异动,股价快速下跌5.20%。截至发稿,该股报29.10美元/股,成交量11.583万股,换手率0.05%,振幅4.51%。Onestream, Inc.股票所在的软件服务行业中,整体跌幅为0.39%。Onestream, Inc.公司简介:OneStream Inc 是一个支持人工智能的可扩展软件平台,将核心财务功能和更广泛的运营数据和流程统一到一个平台上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209234313984ac843&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209234313984ac843&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4097","OS"],"gpt_icon":0},{"id":"2488237929","title":"Onestream, Inc.盤中異動 股價大漲5.01%報31.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488237929","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488237929?lang=zh_tw&edition=fundamental","pubTime":"2024-12-04 02:00","pubTimestamp":1733248824,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日02时00分,Onestream, Inc.股票出现异动,股价快速拉升5.01%。截至发稿,该股报31.85美元/股,成交量79.9627万股,换手率0.34%,振幅5.31%。Onestream, Inc.股票所在的软件服务行业中,整体跌幅为0.05%。Onestream, Inc.公司简介:OneStream Inc 是一个支持人工智能的可扩展软件平台,将核心财务功能和更广泛的运营数据和流程统一到一个平台上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204020024a269f3a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204020024a269f3a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4097","OS"],"gpt_icon":0},{"id":"2488962937","title":"無AI,不手機?","url":"https://stock-news.laohu8.com/highlight/detail?id=2488962937","media":"蓝洞商业","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488962937?lang=zh_tw&edition=fundamental","pubTime":"2024-12-03 15:52","pubTimestamp":1733212336,"startTime":"0","endTime":"0","summary":"2拼 AI,就是比系统让苹果如此着急的首要原因,就是国产手机厂商的努力,它们在争抢苹果 AI 落地中国的窗口期。实际上,国产厂商们在 AI 手机上的追求是一致的。AI 智能助手这个调度者,将降低用户操作手机的复杂程度,也将带来新的交互方式。而从节奏上来说,明年 AI 手机才会真正走向成熟期。因为 12 月到明年上半年,国产 AI 手机操作系统才将逐步发版推开到市场中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8f0tdfYvGdW","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["GB00BDT5M118.USD","IE00B4JS1V06.HKD","LU0251132253.USD","LU0238689110.USD","LU2458330169.SGD","IE00BLSP4452.SGD","IE0004445239.USD","BK4553","SGXZ31699556.SGD","LU1868836757.USD","LU0861579265.USD","LU2247934214.USD","LU0820561818.USD","LU0949170772.SGD","LU1066051811.HKD","LU1674673428.USD","LU1046421795.USD","LU1934455277.USD","SG9999014898.SGD","IE0009356076.USD","LU0719512351.SGD","LU2083900584.USD","IE00BFSS7M15.SGD","LU0724617625.USD","LU2065171402.SGD","HK0000306701.USD","LU0061474960.USD","IE00BK4W5L77.USD","LU1366333091.USD","IE00BLSP4239.USD","LU1235294995.USD","LU0096364046.USD","LU1935042991.SGD","LU0149725797.USD","LU2237443549.SGD","AAPL","LU2361045086.USD","LU1582986433.USD","LU0353189680.USD","LU1261432733.SGD","LU0170899867.USD","SG9999017495.SGD","LU0494093205.USD","LU0234572021.USD","LU0077335932.USD","OS","SG9999002224.SGD","BK4581","IT","SG9999000418.SGD"],"gpt_icon":1},{"id":"2486807360","title":"Onestream, Inc.盤中異動 股價大跌5.02%報30.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486807360","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486807360?lang=zh_tw&edition=fundamental","pubTime":"2024-11-28 05:00","pubTimestamp":1732741215,"startTime":"0","endTime":"0","summary":"北京时间2024年11月28日05时00分,Onestream, Inc.股票出现波动,股价快速下挫5.02%。截至发稿,该股报30.39美元/股,成交量56.9519万股,换手率0.24%,振幅5.45%。Onestream, Inc.股票所在的软件服务行业中,整体跌幅为1.23%。Onestream, Inc.公司简介:OneStream Inc 是一个支持人工智能的可扩展软件平台,将核心财务功能和更广泛的运营数据和流程统一到一个平台上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112805001598e45020&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112805001598e45020&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4097","OS"],"gpt_icon":0},{"id":"2485929519","title":"吉利德近期宣佈多個裁員計劃:腫瘤業務遇阻,一年兩針的艾滋病“神藥”能否撐起未來?","url":"https://stock-news.laohu8.com/highlight/detail?id=2485929519","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485929519?lang=zh_tw&edition=fundamental","pubTime":"2024-11-23 00:35","pubTimestamp":1732293328,"startTime":"0","endTime":"0","summary":"日前,知名跨国药企吉利德宣布了新一轮裁员计划,此举在医药行业引发了广泛关注。值得注意的是,此次裁员计划并非吉利德近期的唯一调整动作。公司称这一业绩增长主要得益于艾滋病、肿瘤和肝病领域的良好销售情况。第三季度,吉利德的肿瘤业务共实现营收8.16亿美元,同比增长6%。对比之下,第三季度销售额同比增长17%至3.32亿美元的Trodelvy则成为了吉利德肿瘤业务的唯一亮点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123003651a24e565f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123003651a24e565f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OS","BK4097","BK4566","LU1571399168.USD","LU2087621335.USD","BK4585","LU1585245621.USD","BK4578","IE00B19Z3581.USD","LU0289739699.SGD","IE0002270589.USD","LU0058720904.USD","LU0234570918.USD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","GILD","BK4532","LU0109394709.USD","LU0889565916.HKD","BK4139","BK4583","LU1430594728.SGD","LU1066051498.USD","BK4568","LU1066053197.SGD","LU1839511570.USD","BK4588","LU0320765992.SGD","LU2468319806.SGD","IE00BKVL7J92.USD","BK4550"],"gpt_icon":0},{"id":"2484924961","title":"吉利德腫瘤藥賣不動了?新藥失利、裁員調整","url":"https://stock-news.laohu8.com/highlight/detail?id=2484924961","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484924961?lang=zh_tw&edition=fundamental","pubTime":"2024-11-20 19:51","pubTimestamp":1732103461,"startTime":"0","endTime":"0","summary":"目前,吉利德的肿瘤产品线拥有三款重磅药物,分别是细胞治疗领域的两款CD19 CAR-T产品Tecartus和Yescarta,以及TROP2 ADC药物Trodelvy。这一决定无疑对吉利德在肿瘤领域的战略布局产生了深远影响。近日,吉利德披露了一系列裁员计划,这一举措被业内视为其在当前困境下的无奈之举。总的来看,吉利德的新药失利与裁员计划是当前生物制药领域竞争激烈和市场变化的真实写照。近日,吉利德宣布了一项重大裁员计划,引发业界广泛关注。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120195516abd1e427&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120195516abd1e427&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IE00BKVL7J92.USD","LU1066053197.SGD","LU1066051498.USD","BK4568","BK4566","IE00BSNM7G36.USD","BK4195","LU0109394709.USD","IE00BZ1G4Q59.USD","BK4583","LU1839511570.USD","IE0002270589.USD","BK4532","BK4211","BK4578","IE00B19Z3B42.SGD","LU1430594728.SGD","BK4588","BK4097","GILD","OS","BK4585","LU0234570918.USD","LU0889565916.HKD","LU2468319806.SGD","LU2087621335.USD","LU1571399168.USD","PFS","LU0058720904.USD","LU0289739699.SGD","LU0320765992.SGD","LU1585245621.USD","BK4550","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2484510422","title":"Onestream, Inc.2024財年第三財季實現淨利潤-1.72億美元,同比減少2644.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484510422","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484510422?lang=zh_tw&edition=fundamental","pubTime":"2024-11-17 00:03","pubTimestamp":1731773017,"startTime":"0","endTime":"0","summary":"11月17日,Onestream, Inc.公布财报,公告显示公司2024财年第三财季净利润为-1.72亿美元,同比减少2644.38%;其中营业收入为1.29亿美元,同比增加20.56%,每股基本收益为-0.73美元。从资产负债表来看,Onestream, Inc.总负债2.92亿美元,其中短期债务3.32百万美元,资产负债比为2.57,流动比率为2.38。机构评级:截至2024年11月17日,当前有14家机构对Onestream, Inc.目标价做出预测,其中目标均价为36.21美元,其中最低目标价为30.00美元,最高目标价为39.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000444a23e0730&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000444a23e0730&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OS"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":69,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OS\",params:#limit:5,,,undefined,":[{"date":"2025-05-08","symbol":"OS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-0.06,"defaultRemindTime":1746734400000,"name":null,"time":"盤後","dateTimestamp":1746676800000,"actualEps":null},{"market":"US","date":"2025-02-11","symbol":"OS","fiscalQuarterEnding":"2024/12","expectedEps":0.02,"name":null,"time":"盤後","type":"earning","dateTimestamp":1739250000000,"reportTimeType":"post","actualEps":0.07},{"market":"US","date":"2024-11-07","symbol":"OS","fiscalQuarterEnding":"2024/09","expectedEps":0,"name":null,"time":"盤後","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-1.06},{"market":"US","date":"2024-09-03","symbol":"OS","fiscalQuarterEnding":"2024/06","expectedEps":-0.11,"name":null,"time":"盤後","type":"earning","dateTimestamp":1725336000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.5556,"hold":0.1111,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5556,"analysts":18,"updateTime":1742356800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OS","date":"2025-04-28","current":-17.333565,"percent":0.89011,"low":-1655.61542,"twenty":-1414.621664,"median":-27.407231,"eighty":-18.799104,"high":-14.493656,"avg":-429.05566,"sd":616.357181,"marketCap":3747533991},"quantilePoints":[{"date":"2024-08-02","current":-402.058638,"twenty":-402.058638,"median":-402.058638,"eighty":-402.058638,"marketCap":4348264172},{"date":"2024-08-09","current":-394.529993,"twenty":-398.004752,"median":-394.602383,"eighty":-391.489578,"marketCap":4266841869},{"date":"2024-08-16","current":-420.156344,"twenty":-402.058638,"median":-395.977809,"eighty":-394.529993,"marketCap":4543990864},{"date":"2024-08-23","current":-418.563746,"twenty":-420.156344,"median":-400.248867,"eighty":-394.674774,"marketCap":4526766915},{"date":"2024-08-30","current":-439.701867,"twenty":-427.829772,"median":-415.668113,"eighty":-395.977809,"marketCap":4755375690},{"date":"2024-09-06","current":-1412.285699,"twenty":-434.093948,"median":-420.156344,"eighty":-395.977809,"marketCap":4652069092},{"date":"2024-09-13","current":-1421.532228,"twenty":-630.517125,"median":-426.381956,"eighty":-397.599363,"marketCap":4682527160},{"date":"2024-09-20","current":-1491.611188,"twenty":-1406.835113,"median":-428.55368,"eighty":-398.352228,"marketCap":4913367253},{"date":"2024-09-27","current":-1641.015636,"twenty":-1479.542034,"median":-435.672004,"eighty":-401.33473,"marketCap":5405505506},{"date":"2024-10-04","current":-1582.129844,"twenty":-1582.616503,"median":-445.348351,"eighty":-408.313205,"marketCap":5211535706},{"date":"2024-10-11","current":-1384.546111,"twenty":-1557.991535,"median":-1361.673117,"eighty":-414.50986,"marketCap":4560694889},{"date":"2024-10-18","current":-1422.505547,"twenty":-1506.405635,"median":-1387.466067,"eighty":-417.984619,"marketCap":4685733272},{"date":"2024-10-25","current":-1513.510863,"twenty":-1501.052381,"median":-1410.582391,"eighty":-419.837824,"marketCap":4985504782},{"date":"2024-10-31","current":-1488.204572,"twenty":-1545.825049,"median":-1419.58559,"eighty":-422.588676,"marketCap":4902145859},{"date":"2024-11-08","current":-29.444986,"twenty":-1544.267739,"median":-1421.532228,"eighty":-422.588676,"marketCap":5359016876},{"date":"2024-11-15","current":-29.547337,"twenty":-1525.190689,"median":-1414.232336,"eighty":-406.749563,"marketCap":5377644907},{"date":"2024-11-22","current":-27.361909,"twenty":-1504.167001,"median":-1405.472467,"eighty":-395.977809,"marketCap":4979894851},{"date":"2024-11-29","current":-26.339693,"twenty":-1496.769778,"median":-1384.546111,"eighty":-392.705744,"marketCap":4793850470},{"date":"2024-12-06","current":-28.33551,"twenty":-1493.655158,"median":-903.058146,"eighty":-29.829328,"marketCap":5157091209},{"date":"2024-12-13","current":-28.454992,"twenty":-1490.248542,"median":-439.701867,"eighty":-28.749622,"marketCap":5178836972},{"date":"2024-12-20","current":-27.223413,"twenty":-1484.895288,"median":-431.521704,"eighty":-28.258307,"marketCap":4954688343},{"date":"2024-12-27","current":-27.048786,"twenty":-1479.834029,"median":-428.191726,"eighty":-28.004145,"marketCap":4922906075},{"date":"2025-01-03","current":-25.973452,"twenty":-1479.444702,"median":-426.381956,"eighty":-27.732022,"marketCap":4727194212},{"date":"2025-01-10","current":-24.227183,"twenty":-1479.444702,"median":-422.183287,"eighty":-27.252823,"marketCap":4409371530},{"date":"2025-01-17","current":-26.460569,"twenty":-1468.54353,"median":-415.668113,"eighty":-26.869269,"marketCap":4815850013},{"date":"2025-01-24","current":-27.894348,"twenty":-1465.818237,"median":-402.058638,"eighty":-26.861301,"marketCap":5076799163},{"date":"2025-01-31","current":-27.407231,"twenty":-1462.314289,"median":-396.991281,"eighty":-26.925021,"marketCap":4988143362},{"date":"2025-02-07","current":-27.09474,"twenty":-1459.102337,"median":-394.674774,"eighty":-26.925021,"marketCap":4931269830},{"date":"2025-02-14","current":-19.646244,"twenty":-1457.642359,"median":-390.041762,"eighty":-26.782239,"marketCap":4247537655},{"date":"2025-02-21","current":-19.437413,"twenty":-1455.695721,"median":-30.305187,"eighty":-26.72172,"marketCap":4202388031},{"date":"2025-02-28","current":-18.385222,"twenty":-1452.094441,"median":-29.520901,"eighty":-26.562732,"marketCap":3974903390},{"date":"2025-03-07","current":-18.486889,"twenty":-1446.059864,"median":-28.777108,"eighty":-26.339693,"marketCap":3996883783},{"date":"2025-03-14","current":-16.449855,"twenty":-1440.122619,"median":-28.454992,"eighty":-26.179328,"marketCap":3556475076},{"date":"2025-03-21","current":-17.921046,"twenty":-1437.981318,"median":-28.198548,"eighty":-25.317223,"marketCap":3874548031},{"date":"2025-03-28","current":-18.76981,"twenty":-1430.38943,"median":-27.986257,"eighty":-24.094834,"marketCap":4058051659},{"date":"2025-04-04","current":-16.296269,"twenty":-1422.116219,"median":-27.889753,"eighty":-20.198845,"marketCap":3523269657},{"date":"2025-04-11","current":-15.87621,"twenty":-1419.974918,"median":-27.820821,"eighty":-19.520945,"marketCap":3432452458},{"date":"2025-04-17","current":-15.802935,"twenty":-1417.346957,"median":-27.682957,"eighty":-19.180725,"marketCap":3416610370},{"date":"2025-04-25","current":-17.317281,"twenty":-1415.400319,"median":-27.425612,"eighty":-18.846182,"marketCap":3744013527},{"date":"2025-04-28","current":-17.333565,"twenty":-1414.621664,"median":-27.407231,"eighty":-18.799104,"marketCap":3747533991}],"updateTime":1745982375121}}}